OIRA Conclusion of EO 12866 Regulatory Review
| RIN: 0910-AG81 View EO 12866 Meetings | Received Date: 03/11/2014 |
| Title: Requirements for the Submission of Data Needed to Calculate User Fees for Domestic Manufacturers and Importers of Tobacco Products | |
| Agency/Subagency: HHS / FDA | Stage: Final Rule |
| Concluded Action: Consistent with Change | Concluded Date: 06/23/2014 |
| Legal Deadline: None | Economically Significant: No |
| Publication Date: 07/10/2014 | Unfunded Mandates: No |
| Major: No | Related To Homeland Security: No |
| Regulatory Flexibility Analysis Required: Yes | Small Entities Affected: Businesses |
| Federalism Implications: No | Affordable Care Act [Pub. L. 111-148 & 111-152]: No |
| International Impacts: No | Dodd-Frank Wall Street Reform and Consumer Protection Act, [Pub. L. 111-203]: No |
| Pandemic Response: Uncollected | |
An official website of the United States government




